Interleukin-1 increases fibronectin production by cultured rat cardiac fibroblasts

被引:16
作者
Fernández, L
Mosquera, JA
机构
[1] Univ Zulia, Inst Invest Clin Dr Amer Negrette, Fac Med, Maracaibo, Venezuela
[2] Univ Zulia, Ctr Cirugia Expt, Maracaibo, Venezuela
关键词
fibronectin; fibrosis; cardiac fibroblast; interleukin-1; myocarditis;
D O I
10.1159/000069328
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Objectives: There is evidence of monocyte/macrophage infiltration and increased interleukin (IL)-1 expression, along with increased extracellular matrix (ECM) and fibrosis in the myocardial interstitium, during the course of parasitic, viral and idiopathic myocarditis. The aim of this study was to determine the effect of human and rat IL-1 on the production of fibronectin (FN) by rat cardiac fibroblast cultures. Methods:To test the role of IL-1 in the production of ECM, we determined the FN content in supernatants of rat myocardial fibroblast cultures incubated for 72 h with different doses of human recombinant IL-1 P or with supernatants from lipopolysaccharide (LPS)-stimulated rat macrophage cultures. The content of soluble FN was determined by ELISA. In addition, IL-1beta transcription was also investigated in controls and human recombinant IL-1beta-treated fibroblast cultures. Results:There was a significant, dose-dependent FN-stimulatory effect of recombinant human IL-1beta and LPS-stimulated macrophage-conditioned medium when they were used to stimulate fibroblast cultures. The stimulatory effect on FN production was found to be diminished after treatment of macrophage supernatants with an antibody against rat IL-1. Increased transcription of IL-1beta was found in human recombinant IL-1beta-treated cardiac fibroblasts. Conclusion: Our data suggest that the FN-stimulatory effect of IL-1 on cardiac fibroblasts could be responsible, in part, for interstitial ECM accumulation during the course of myocarditis. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 49 条
[11]   Plasma cytokine levels in cardiac chambers of patients with mitral stenosis with congestive heart failure [J].
Ikeda, U ;
Yamamoto, K ;
Akazawa, H ;
Hojo, Y ;
Ohkawa, F ;
Fujikawa, H ;
Sekiguchi, H ;
Shimada, K .
CARDIOLOGY, 1996, 87 (06) :476-480
[12]   PATHOPHYSIOLOGICAL CORRELATES OF INCREASED SERUM TUMOR-NECROSIS-FACTOR IN PATIENTS WITH CONGESTIVE-HEART-FAILURE - RELATION TO NITRIC OXIDE-DEPENDENT VASODILATION IN THE FOREARM CIRCULATION [J].
KATZ, SD ;
RAO, R ;
BERMAN, JW ;
SCHWARZ, M ;
DEMOPOULOS, L ;
BIJOU, R ;
LEJEMTEL, TH .
CIRCULATION, 1994, 90 (01) :12-16
[13]  
KEOGH AM, 1990, BRIT HEART J, V64, P406
[14]   FIBROGENIC CYTOKINES - THE ROLE OF IMMUNE MEDIATORS IN THE DEVELOPMENT OF SCAR TISSUE [J].
KOVACS, EJ .
IMMUNOLOGY TODAY, 1991, 12 (01) :17-23
[15]  
KURTJONES EA, 1985, J IMMUNOL, V135, P1548
[16]  
LANE JR, 1993, J IMMUNOL, V151, P1682
[17]   EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-1 ON ELECTRICAL-PROPERTIES OF GUINEA-PIG VENTRICULAR CELLS [J].
LI, YH ;
ROZANSKI, GJ .
CARDIOVASCULAR RESEARCH, 1993, 27 (03) :525-530
[18]   CYTOKINES AS MODULATORS OF CELL-PROLIFERATION IN FIBROTIC DISEASES [J].
LIBBY, P ;
FRIEDMAN, GB ;
SALOMON, RN .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (04) :1114-1117
[19]   INTERLEUKIN-1-BETA MESSENGER-RNA EXPRESSION IN ISCHEMIC RAT CORTEX [J].
LIU, T ;
MCDONNELL, PC ;
YOUNG, PR ;
WHITE, RF ;
SIREN, AL ;
HALLENBECK, JM ;
BARONE, FC ;
FEURERSTEIN, GZ .
STROKE, 1993, 24 (11) :1746-1751
[20]  
LONG CS, 1993, CLIN RES, V41, pA145